Release Date: August 29, 2025
Expiration Date: August 29, 2026
Activity Overview
The underlying pathophysiology of pulmonary arterial hypertension (PAH), a variant of pulmonary hypertension, originates in the pulmonary vasculature. Due to the rarity of PAH, few pediatric patients receive specialized therapy. In this video-based program, a pediatric pulmonologist and a pediatric cardiologist provide an overview for pediatricians and other health care providers about the diagnosis of PAH, its classification, its common comorbidities, and a review of therapies used to manage pediatric PAH.
Target Audience
This educational activity is directed toward pediatricians, cardiologists, pulmonologists, nurse practitioners, physician assistants, registered nurses, and other health care professionals who treat pediatric patients with PAH.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the etiologies, signs, and symptoms of PAH in pediatric patients
- Evaluate pediatric patients with suspected PAH according to current recommendations for diagnosis and risk stratification
- Explain the pathophysiologic pathways and treatment targets in PAH
- Summarize available data on targeted therapies for pediatric PAH to support clinical decision-making
- Develop treatment plans for patients with pediatric PAH that include pediatricians as part of a multidisciplinary team to optimize clinical outcomes and quality of life
Jean M. Elwing, MD, FCCP
Professor of Medicine
Director, Pulmonary Hypertension Program
Pulmonary Hypertension Association Certified Center (PHCCC)
Pulmonary, Critical Care and Sleep Medicine
University of Cincinnati
Cincinnati, OH
Disclosures: Consulting/Advising: Aerovate, Gossamer Bio, Insmed, Janssen/Actelion/Johnson & Johnson, Liquidia, Merck, Pulmovant, United Therapeutics; Grant/Research Funding: Acceleron/Merck, Actelion/Janssen/Johnson & Johnson, Aerovate, Altavant, Gossamer Bio, Lung LLC, Pharmosa/Liquidia, Pulmovant
Russel Hirsch, MD
Director, Pulmonary Hypertension Service
Professor of Pediatrics
The Hert Institute
Cincinnati Children’s Hospital Medical Center
University of Cincinnati College of Medicine
Cincinnati, OH
Russel Hirsch, MD, has no relevant financial relationships with ineligible companies
John F. Morehous, MD
Associate Professor, Division of General Pediatrics
University of Cincinnati College of Medicine
Medical Director
Cincinnati Children’s Community Health Services Network
Cincinnati, OH
John F. Morehous, MD, has no relevant financial relationships with ineligible companies.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here